Testing effectiveness (Phase 2)Study completedNCT01850381What this trial is testingPhase 2A Study of GM 608 in Mild to Moderate Parkinson DiseaseWho this might be right forParkinson's Disease Genervon Biopharmaceuticals, LLC 6